PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCM21
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $222,027
Award facts
- Contract value 100% obligated
- $222,026.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $222,026.71 on January 15, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, competitively awarded contract (CAGE 0U9U0) carries an ultimate completion date of January 16, 2026 and represents a non-set-aside procurement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and test kits across multiple therapeutic domains.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which also does business as AmerisourceBergen and serves as the parent entity holding the primary IDC relationship with DLA Troop Support Medical. The company's federal contracting activities demonstrate consistent capability in meeting defense medical procurement requirements through open competition, with deliverables supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards to separate regional contractors, positioning AmerisourceBergen among key vendors in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2D826FCM21?
SPE2D826FCM21 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 15, 2026.
How much is contract SPE2D826FCM21 worth?
The government has obligated $222,027 on SPE2D826FCM21.
Is contract SPE2D826FCM21 an order under another contract?
Yes. SPE2D826FCM21 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FCM21 competed?
The extent of competition for SPE2D826FCM21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award